Valuation: North China Pharmaceutical Company.Ltd

Market Cap 7.7B 1.13B 992M 914M 847M 1.61B 108B 1.63B 10.96B 4.26B 53.1B 4.26B 4.16B 184B P/E 2024
69.9x
P/E 2025 51.7x
Enterprise Value 17.38B 2.56B 2.24B 2.06B 1.91B 3.63B 243B 3.69B 24.73B 9.62B 120B 9.6B 9.39B 414B EV / Sales 2024
1.89x
EV / Sales 2025 2.07x
Free-Float
40.58%
Yield 2024
0.58%
Yield 2025 0.63%
1 day-3.23%
1 week+1.81%
Current month+5.15%
1 month+1.35%
3 months-18.51%
6 months-20.11%
Current year-18.81%
1 week 4.21
Extreme 4.21
4.68
1 month 4.11
Extreme 4.11
4.68
Current year 4.11
Extreme 4.11
6.07
1 year 4.11
Extreme 4.11
7.46
3 years 3.83
Extreme 3.83
7.46
5 years 3.83
Extreme 3.83
13.45
10 years 3.83
Extreme 3.83
20.24
Manager TitleAgeSince
Chief Executive Officer 55 2025-11-27
Director of Finance/CFO 46 2024-04-09
Investor Relations Contact 45 -
Director TitleAgeSince
Chairman 49 2016-03-21
Director/Board Member 53 2021-04-22
Director/Board Member 54 2022-10-11
Date Insider Type Main position Quantity % Market Cap.
25-02-24Buy

Chairman

1,600 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-3.23%+1.81%-30.39%-19.53% 1.17B
+2.96%+3.01%+59.87%+173.31% 1,070B
+3.05%+5.23%+72.11%+67.81% 624B
-0.04%+1.20%+35.72%+87.93% 450B
-2.58%-2.07%+27.62%+22.57% 328B
+1.36%+0.17%+29.90%+49.33% 284B
+1.98%+4.08%-25.78%-39.02% 217B
+0.45%+1.65%+25.65%+68.35% 198B
+5.21%+7.93%+21.99%+83.23% 161B
+1.48%-0.04%-4.64%-32.25% 135B
Average +0.46%+2.05%+21.21%+46.17% 346.86B
Weighted average by Cap. +0.29%+2.51%+41.82%+87.31%

Financials

2024 2025
Net sales 9.87B 1.45B 1.27B 1.17B 1.09B 2.06B 138B 2.09B 14.05B 5.46B 68.03B 5.45B 5.33B 235B 9.24B 1.36B 1.19B 1.1B 1.02B 1.93B 129B 1.96B 13.15B 5.11B 63.7B 5.11B 5B 220B
Net income 127M 18.69M 16.35M 15.07M 13.97M 26.52M 1.77B 26.95M 181M 70.28M 875M 70.16M 68.65M 3.03B 183M 26.94M 23.58M 21.73M 20.14M 38.23M 2.56B 38.84M 261M 101M 1.26B 101M 98.95M 4.36B
Net Debt 9.79B 1.44B 1.26B 1.16B 1.08B 2.04B 137B 2.08B 13.93B 5.42B 67.48B 5.41B 5.29B 233B 9.67B 1.42B 1.25B 1.15B 1.06B 2.02B 135B 2.05B 13.77B 5.35B 66.68B 5.34B 5.23B 230B
Logo North China Pharmaceutical Company.Ltd
North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
9,972
Date Price Change Volume
26-07-07 CN¥4.490 -3.23% 18,867,111
26-07-06 CN¥4.640 +1.09% 23,258,930
26-07-03 CN¥4.590 +1.77% 20,442,246
26-07-02 CN¥4.510 +1.12% 22,798,307
26-07-01 CN¥4.460 +4.45% 24,761,326

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600812 Stock